Canada's Valeant Pharmaceuticals International Inc said it has agreed to purchase Russian pharma company Natur Produkt International, JSC for about $180 million, with an additional $5 million in potential future milestones. The transaction is expected to close by mid-year 2012, Valeant said in a statement.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX remained unchanged at $53.70. In the past year, the shares have traded as low as $33.91 and as high as $55.24. On average, 631684 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 0.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX remained unchanged at $53.75. In the past year, the shares have traded as low as $32.05 and as high as $57.24. On average, 1891980 shares of VRX exchange hands on a given day and today's volume is recorded at 100.
Source
